These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17222383)

  • 1. Costs of interventions for visual impairment.
    Taylor HR; Pezzullo ML; Nesbitt SJ; Keeffe JE
    Am J Ophthalmol; 2007 Apr; 143(4):561-5. PubMed ID: 17222383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic impact and cost of visual impairment in Australia.
    Taylor HR; Pezzullo ML; Keeffe JE
    Br J Ophthalmol; 2006 Mar; 90(3):272-5. PubMed ID: 16488942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LXIII Edward Jackson Memorial Lecture: Eye care: dollars and sense.
    Taylor HR
    Am J Ophthalmol; 2007 Jan; 143(1):1-8. PubMed ID: 17188039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical care cost of Medicare/Medicaid beneficiaries with vision loss.
    Morse AR; Pyenson BS
    Ophthalmic Epidemiol; 2009; 16(1):50-7. PubMed ID: 19191182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personal costs of visual impairment by different eye diseases and severity of visual loss.
    Wong EY; Chou SL; Lamoureux EL; Keeffe JE
    Ophthalmic Epidemiol; 2008; 15(5):339-44. PubMed ID: 18850471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of visual impairment: purposes, perspectives, and guidance.
    Frick KD; Kymes SM; Lee PP; Matchar DB; Pezzullo ML; Rein DB; Taylor HR;
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1801-5. PubMed ID: 20071669
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jan; 53(3):57-9. PubMed ID: 14749614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An estimation of the worldwide economic and health burden of visual impairment.
    Gordois A; Cutler H; Pezzullo L; Gordon K; Cruess A; Winyard S; Hamilton W; Chua K
    Glob Public Health; 2012; 7(5):465-81. PubMed ID: 22136197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic cost of visual impairment in Japan.
    Roberts CB; Hiratsuka Y; Yamada M; Pezzullo ML; Yates K; Takano S; Miyake K; Taylor HR
    Arch Ophthalmol; 2010 Jun; 128(6):766-71. PubMed ID: 20547955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in access to medical care for individuals with vision impairment.
    Spencer C; Frick K; Gower EW; Kempen JH; Wolff JL
    Ophthalmic Epidemiol; 2009; 16(5):281-8. PubMed ID: 19874107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of vision impairment in childhood and youth: diary case studies.
    O'Connor PM; Chou SL; Lamoureux EL; Keeffe JE
    Optom Vis Sci; 2008 Nov; 85(11):1106-9. PubMed ID: 18981926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons for not seeking eye care among adults aged ≥40 years with moderate-to-severe visual impairment--21 States, 2006-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(19):610-3. PubMed ID: 21597453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grading contact lens-related microbial keratitis: relevance to disease burden.
    Keay L; Edwards K; Dart J; Stapleton F
    Optom Vis Sci; 2008 Jul; 85(7):531-7. PubMed ID: 18594345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and causes of functional low vision and implications for services: the Pakistan National Blindness and Visual Impairment Survey.
    Shah SP; Minto H; Jadoon MZ; Bourne RR; Dineen B; Gilbert CE; Khan MD;
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):887-93. PubMed ID: 18326708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL; Yu F
    Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Visual impairment -- implications on health, costs and predictions for the future].
    Müller A
    Klin Monbl Augenheilkd; 2005 Jan; 222(1):32-5. PubMed ID: 15678397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey.
    Abdull MM; Sivasubramaniam S; Murthy GV; Gilbert C; Abubakar T; Ezelum C; Rabiu MM;
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4114-20. PubMed ID: 19387071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.